Volume 18, Number 7—July 2012
Research
Validity of International Health Regulations in Reporting Emerging Infectious Diseases
Table 2
Characteristics of 175 EID events reported to WHO*
Characteristic | No. (%) |
---|---|
Type of pathogen | |
Bacterium | 89 (50.9) |
Virus | 39 (22.3) |
Rickettsia | 12 (6.9) |
Protozoan | 20 (11.4) |
Helminth | 2 (1.1) |
Fungus | 12 (6.9) |
Prion | 1 (0.6) |
WHO region | |
AMRO | 77 (44.0) |
EURO | 49 (28.0) |
EMRO | 7 (4.0) |
SEARO | 10 (5.7) |
WPRO | 24 (13.7) |
AFRO | 8 (4.6) |
Type of event | |
New pathogen | 70 (40.0) |
Increased incidence | 44 (25.1) |
Antimicrobial drug resistance | 54 (30.9) |
New clinical manifestation | 7 (4.0) |
*EID, emerging infectious disease; WHO, World Health Organization; AMRO, Americas; EURO, Europe; EMRO, Eastern Mediterranean; SEARO, Southeast Asia; WPRO, Western Pacific; AFRO, Africa.